Danaher Corporation (DHR) PT Set at $96.00 by Citigroup Inc.

Citigroup Inc. set a $96.00 target price on Danaher Corporation (NYSE:DHR) in a research report report published on Friday, July 21st. The firm currently has a buy rating on the conglomerate’s stock.

Other equities research analysts have also recently issued reports about the stock. BTIG Research reiterated a buy rating and issued a $92.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. Zacks Investment Research cut shares of Danaher Corporation from a hold rating to a sell rating in a report on Wednesday, July 12th. Royal Bank Of Canada reiterated a sector perform rating and issued a $88.00 price objective (down from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. BidaskClub upgraded shares of Danaher Corporation from a sell rating to a hold rating in a report on Wednesday, July 19th. Finally, Wells Fargo & Company initiated coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a market perform rating and a $90.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $91.76.

Shares of Danaher Corporation (DHR) traded down 0.05% during midday trading on Friday, reaching $80.87. The company’s stock had a trading volume of 2,861,306 shares. The stock’s 50 day moving average is $82.32 and its 200 day moving average is $84.22. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The stock has a market capitalization of $56.18 billion, a PE ratio of 25.81 and a beta of 1.03.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. During the same period in the previous year, the company posted $0.90 EPS. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. On average, analysts forecast that Danaher Corporation will post $3.95 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was posted by BNB Daily and is the property of of BNB Daily. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/19/danaher-corporation-dhr-given-a-96-00-price-target-by-citigroup-inc-analysts-updated-updated-updated.html.

In other Danaher Corporation news, SVP Angela S. Lalor sold 10,815 shares of the company’s stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the sale, the senior vice president now directly owns 39,020 shares of the company’s stock, valued at $3,283,923.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the sale, the insider now directly owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock valued at $3,206,426 in the last three months. Company insiders own 12.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of the company. GQG Partners LLC purchased a new stake in shares of Danaher Corporation during the second quarter valued at $101,000. Peddock Capital Advisors LLC boosted its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. Proficio Capital Partners LLC boosted its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares in the last quarter. Monetary Management Group Inc. boosted its stake in shares of Danaher Corporation by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after buying an additional 150 shares in the last quarter. Finally, Acrospire Investment Management LLC boosted its stake in shares of Danaher Corporation by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after buying an additional 1,100 shares in the last quarter. 76.12% of the stock is currently owned by hedge funds and other institutional investors.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Analyst Recommendations for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply